
Loading, please wait...

Loading, please wait...

Clinicians constantly seek early indicators for obstetric complications. Recent research highlights a significant link between first-trimester fetal heart rate preterm birth risk. This prospective cohort study aimed to validate if the fetal heart rate (FHR) measured during the routine 12-week scan can serve as a reliable predictor for spontaneous and overall preterm delivery.
Researchers conducted a prospective cohort study involving 1,276 singleton pregnancies. These patients underwent routine first-trimester screening between 11 and 13 + 6 weeks' gestation. The team monitored these pregnancies until delivery to assess the association between FHR and birth outcomes. They utilized multivariable logistic regression and ROC curves to analyze clinical, biochemical, and sonographic parameters. Consequently, the study provided a robust framework for assessing early gestation markers.
The results revealed that pregnancies ending in preterm birth (PTB) had significantly higher heart rates at the 12-week scan. Specifically, the mean FHR for PTB cases was 163.6 bpm compared to 160.1 bpm for term births (p = .007). For spontaneous preterm birth (sPTB), the mean FHR was 164.1 bpm. Interestingly, FHR was the only parameter consistently associated with PTB in the univariable analysis. Therefore, this measurement offers unique prognostic value during early antenatal care.
Incorporating FHR into existing screening protocols may enhance early risk stratification. Although the difference in beats per minute appears small, it provides a statistically significant marker for identifying high-risk pregnancies. Clinicians should consider these findings when interpreting routine first-trimester scans. Early identification allows for closer monitoring and potentially earlier interventions to improve neonatal outcomes. Moreover, this marker is easily obtainable without additional invasive procedures.
The typical fetal heart rate at 12 weeks' gestation ranges between 150 and 170 bpm. However, this study suggests that rates on the higher end of this spectrum, specifically above 163 bpm, may be associated with an increased risk of preterm delivery.
While FHR is a significant marker, it is most effective when integrated with other clinical parameters. It serves as a valuable tool in a comprehensive risk assessment during the first trimester. Furthermore, combining it with nuchal translucency and maternal history improves predictive accuracy.
Disclaimer: This content is for informational and educational purposes only. It does not constitute professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified healthcare provider with any questions you may have regarding a medical condition. Refer to the latest local and national guidelines for clinical practice.
References

Read summarized clinical updates, watch expert medical content, and earn CME certifications right from your smartphone.


A prospective study validates that higher fetal heart rate at 12 weeks' gestation is significantly associated with an increased risk of preterm birth....
6 months ago

Following Nigeria's first recorded Ebola case linked to regional travel, the Africa CDC has convened an emergency ministerial summit. This alert underscores critical clinical priorities for healthcare professionals, including differentiating early viral infection from malaria, implementing barrier nursing, and triage.
Today

Leucine Rich Bio has introduced South Asia's first comprehensive vaginal microbiome test, BugSpeaks. By profiling microbial dysbiosis, pathogens, and antimicrobial resistance, this next-generation diagnostic platform provides clinicians with deeper insights into recurrent infections, fertility, and reproductive health.
Today

Review how tailored exercise programs benefit frail older patients with heart failure. Explore pathophysiological mechanisms, individualized training prescriptions, and strategies to overcome adherence barriers in clinical practice.
Today

This comparative study evaluates posterior labral tears with and without glenohumeral instability, highlighting distinct demographic patterns, MRI underestimation in stable shoulders, and successful arthroscopic repair outcomes.
Today

A clinical study demonstrates that early intervention with tocilizumab, either as monotherapy or bridged with corticosteroids, achieves significant proptosis reduction and resolves active inflammation in treatment-naive thyroid eye disease.
Today